ENTRY       D10685            Mixture   Drug
NAME        Lumacaftor and ivacaftor;
            Orkambi (TN)
PRODUCT     ORKAMBI (Vertex Pharmaceuticals Incorporated)
COMPONENT   Lumacaftor [DR:D10134], Ivacaftor [DR:D09916]
REMARK      ATC code: R07AX30
            Product: D10685<US>
EFFICACY    Cystic fibrosis treatment
  DISEASE   Cystic fibrosis (CFTR F508del homozygous mutation) [DS:H00218]
COMMENT     Treatment of cystic fibrosis (CF)
TARGET      CFTR* [HSA_VAR:1080v1] [HSA:1080] [KO:K05031]
  PATHWAY   hsa02010(1080)  ABC transporters
            hsa04971(1080)  Gastric acid secretion
            hsa04972(1080)  Pancreatic secretion
            hsa04976(1080)  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R07 OTHER RESPIRATORY SYSTEM PRODUCTS
               R07A OTHER RESPIRATORY SYSTEM PRODUCTS
                R07AX Other respiratory system products
                 R07AX30 Ivacaftor and lumacaftor
                  D10685  Lumacaftor and ivacaftor &lt;US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Cystic Fibrosis Agents
               Conductance Regulator Potentiator
                Lumacaftor/ Ivacaftor
                 D10685  Lumacaftor and ivacaftor
            Target-based classification of drugs [BR:br08310]
             Transporters
              ABC transporters
               ABCC subfamily
                CFTR* [HSA_VAR:1080v1]
                 D10685  Lumacaftor and ivacaftor &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10685
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10685
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10685
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D10685
DBLINKS     CAS: 1815566-23-4
            PubChem: 254741646
            ChEBI: 90950
///
